GENE ONLINE|News &
Opinion
Blog

CRISPR
Blackstone Pumps $250 Million in CAR-T Startup, Betting on Intellia’s and Cellex’s Technologies
2021-06-23
Novel CRISPR Screen Unravels Disease-Related Genes in Neurons
2021-05-31
New Technique Could Challenge CRISPR by Editing Millions of DNA Sites Simultaneously
2021-05-20
Emerging Gene Editing Technologies and Applications
2021-05-19
Inscripta Raises New Capital, Hits a Sales Milestone the Same Day
2021-04-07
A Brief Sketch of Gene Therapy Vectors and Delivery Methods
2021-04-03
Scribe Therapeutics Bags $100 Million in Series B to Advance CRISPR-Based Therapies
2021-04-01
Singapore Researchers Design New C to G Base Editor to Correct Disease-Associated Mutations
2021-03-18
CRISPR-Based Analgesics Aspire to Mitigate Opioid Crisis
2021-03-16
BIOCEO21 Highlights: Novel CRISPR Delivery Method Puts the Spotlight on this Early Stage Biotech
2021-02-18
TALEN Proves to be a Better Gene Editor than CRISPR in Densely Packed DNA
2021-02-01
Scientists Track Cancer cells’ Family Tree via CRISPR to Better Understand Metastasis
2021-01-25
Using Electricity and CRISPR, Scientists Enable Inheritable Data Storage on Bacterial DNA
2021-01-24
JPM Healthcare Conference Highlights: Editas Upbeat about EDIT-101 Success, Verve Continues to Tackle Cholesterol
2021-01-15
Locanabio Raises $100M to Advance CRISPR-Mediated RNA-Targeting Therapies
2020-12-18
1 2 3 4 5 7
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!